Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

Roy G. Cutler, Jeremiah Kelly, Kristin Storie, Ward A. Pedersen, Anita Tammara, Kimmo Hatanpaa, Juan C. Troncoso, Mark P. Mattson

Research output: Contribution to journalArticle

675 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is an age-related disorder characterized by deposition of amyloid β-peptide (Aβ) and degeneration of neurons in brain regions such as the hippocampus, resulting in progressive cognitive dysfunction. The pathogenesis of AD is tightly linked to Aβ deposition and oxidative stress, but it remains unclear as to how these factors result in neuronal dysfunction and death. We report alterations in sphingolipid and cholesterol metabolism during normal brain aging and in the brains of AD patients that result in accumulation of long-chain ceramides and cholesterol. Membrane-associated oxidative stress occurs in association with the lipid alterations, and exposure of hippocampal neurons to Aβ induces membrane oxidative stress and the accumulation of ceramide species and cholesterol. Treatment of neurons with α-tocopherol or an inhibitor of sphingomyelin synthesis prevents accumulation of ceramides and cholesterol and protects them against death induced by Aβ. Our findings suggest a sequence of events in the pathogenesis of AD in which Aβ induces membrane-associated oxidative stress, resulting in perturbed ceramide and cholesterol metabolism which, in turn, triggers a neurodegenerative cascade that leads to clinical disease.

Original languageEnglish (US)
Pages (from-to)2070-2075
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume101
Issue number7
DOIs
StatePublished - Feb 17 2004

Fingerprint

Ceramides
Brain Diseases
Alzheimer Disease
Oxidative Stress
Cholesterol
Membranes
Neurons
Nerve Degeneration
Sphingolipids
Tocopherols
Sphingomyelins
Brain
Amyloid
Hippocampus
Lipids

Keywords

  • Amyloid
  • Apoptosis
  • Hippocampus
  • Lipid peroxidation
  • Sphingomyelin

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. / Cutler, Roy G.; Kelly, Jeremiah; Storie, Kristin; Pedersen, Ward A.; Tammara, Anita; Hatanpaa, Kimmo; Troncoso, Juan C.; Mattson, Mark P.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 7, 17.02.2004, p. 2070-2075.

Research output: Contribution to journalArticle

Cutler, Roy G. ; Kelly, Jeremiah ; Storie, Kristin ; Pedersen, Ward A. ; Tammara, Anita ; Hatanpaa, Kimmo ; Troncoso, Juan C. ; Mattson, Mark P. / Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. In: Proceedings of the National Academy of Sciences of the United States of America. 2004 ; Vol. 101, No. 7. pp. 2070-2075.
@article{4ba2ba2f89444c8381cc20f7b0889b0d,
title = "Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease",
abstract = "Alzheimer's disease (AD) is an age-related disorder characterized by deposition of amyloid β-peptide (Aβ) and degeneration of neurons in brain regions such as the hippocampus, resulting in progressive cognitive dysfunction. The pathogenesis of AD is tightly linked to Aβ deposition and oxidative stress, but it remains unclear as to how these factors result in neuronal dysfunction and death. We report alterations in sphingolipid and cholesterol metabolism during normal brain aging and in the brains of AD patients that result in accumulation of long-chain ceramides and cholesterol. Membrane-associated oxidative stress occurs in association with the lipid alterations, and exposure of hippocampal neurons to Aβ induces membrane oxidative stress and the accumulation of ceramide species and cholesterol. Treatment of neurons with α-tocopherol or an inhibitor of sphingomyelin synthesis prevents accumulation of ceramides and cholesterol and protects them against death induced by Aβ. Our findings suggest a sequence of events in the pathogenesis of AD in which Aβ induces membrane-associated oxidative stress, resulting in perturbed ceramide and cholesterol metabolism which, in turn, triggers a neurodegenerative cascade that leads to clinical disease.",
keywords = "Amyloid, Apoptosis, Hippocampus, Lipid peroxidation, Sphingomyelin",
author = "Cutler, {Roy G.} and Jeremiah Kelly and Kristin Storie and Pedersen, {Ward A.} and Anita Tammara and Kimmo Hatanpaa and Troncoso, {Juan C.} and Mattson, {Mark P.}",
year = "2004",
month = "2",
day = "17",
doi = "10.1073/pnas.0305799101",
language = "English (US)",
volume = "101",
pages = "2070--2075",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "7",

}

TY - JOUR

T1 - Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

AU - Cutler, Roy G.

AU - Kelly, Jeremiah

AU - Storie, Kristin

AU - Pedersen, Ward A.

AU - Tammara, Anita

AU - Hatanpaa, Kimmo

AU - Troncoso, Juan C.

AU - Mattson, Mark P.

PY - 2004/2/17

Y1 - 2004/2/17

N2 - Alzheimer's disease (AD) is an age-related disorder characterized by deposition of amyloid β-peptide (Aβ) and degeneration of neurons in brain regions such as the hippocampus, resulting in progressive cognitive dysfunction. The pathogenesis of AD is tightly linked to Aβ deposition and oxidative stress, but it remains unclear as to how these factors result in neuronal dysfunction and death. We report alterations in sphingolipid and cholesterol metabolism during normal brain aging and in the brains of AD patients that result in accumulation of long-chain ceramides and cholesterol. Membrane-associated oxidative stress occurs in association with the lipid alterations, and exposure of hippocampal neurons to Aβ induces membrane oxidative stress and the accumulation of ceramide species and cholesterol. Treatment of neurons with α-tocopherol or an inhibitor of sphingomyelin synthesis prevents accumulation of ceramides and cholesterol and protects them against death induced by Aβ. Our findings suggest a sequence of events in the pathogenesis of AD in which Aβ induces membrane-associated oxidative stress, resulting in perturbed ceramide and cholesterol metabolism which, in turn, triggers a neurodegenerative cascade that leads to clinical disease.

AB - Alzheimer's disease (AD) is an age-related disorder characterized by deposition of amyloid β-peptide (Aβ) and degeneration of neurons in brain regions such as the hippocampus, resulting in progressive cognitive dysfunction. The pathogenesis of AD is tightly linked to Aβ deposition and oxidative stress, but it remains unclear as to how these factors result in neuronal dysfunction and death. We report alterations in sphingolipid and cholesterol metabolism during normal brain aging and in the brains of AD patients that result in accumulation of long-chain ceramides and cholesterol. Membrane-associated oxidative stress occurs in association with the lipid alterations, and exposure of hippocampal neurons to Aβ induces membrane oxidative stress and the accumulation of ceramide species and cholesterol. Treatment of neurons with α-tocopherol or an inhibitor of sphingomyelin synthesis prevents accumulation of ceramides and cholesterol and protects them against death induced by Aβ. Our findings suggest a sequence of events in the pathogenesis of AD in which Aβ induces membrane-associated oxidative stress, resulting in perturbed ceramide and cholesterol metabolism which, in turn, triggers a neurodegenerative cascade that leads to clinical disease.

KW - Amyloid

KW - Apoptosis

KW - Hippocampus

KW - Lipid peroxidation

KW - Sphingomyelin

UR - http://www.scopus.com/inward/record.url?scp=1242338183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242338183&partnerID=8YFLogxK

U2 - 10.1073/pnas.0305799101

DO - 10.1073/pnas.0305799101

M3 - Article

C2 - 14970312

AN - SCOPUS:1242338183

VL - 101

SP - 2070

EP - 2075

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 7

ER -